DZ2642A1 - Hydrohalogénures 1'-Ä4-Ä1-(fluorphényl)-1h-indole-3ylÜ-1-butylÜ-spiroÄisobenzufuran-1(3h),4'-pipéridineÜ. - Google Patents

Hydrohalogénures 1'-Ä4-Ä1-(fluorphényl)-1h-indole-3ylÜ-1-butylÜ-spiroÄisobenzufuran-1(3h),4'-pipéridineÜ.

Info

Publication number
DZ2642A1
DZ2642A1 DZ980252A DZ980252A DZ2642A1 DZ 2642 A1 DZ2642 A1 DZ 2642A1 DZ 980252 A DZ980252 A DZ 980252A DZ 980252 A DZ980252 A DZ 980252A DZ 2642 A1 DZ2642 A1 DZ 2642A1
Authority
DZ
Algeria
Prior art keywords
spiroäisobenzufuran
piperidineü
butylü
3ylü
fluorphenyl
Prior art date
Application number
DZ980252A
Other languages
English (en)
French (fr)
Inventor
Niels Mark
Heidi Lopez De Diego
Ole Nielsen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Application granted granted Critical
Publication of DZ2642A1 publication Critical patent/DZ2642A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DZ980252A 1997-11-07 1998-11-04 Hydrohalogénures 1'-Ä4-Ä1-(fluorphényl)-1h-indole-3ylÜ-1-butylÜ-spiroÄisobenzufuran-1(3h),4'-pipéridineÜ. DZ2642A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK126797 1997-11-07

Publications (1)

Publication Number Publication Date
DZ2642A1 true DZ2642A1 (fr) 2004-12-28

Family

ID=8102935

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980252A DZ2642A1 (fr) 1997-11-07 1998-11-04 Hydrohalogénures 1'-Ä4-Ä1-(fluorphényl)-1h-indole-3ylÜ-1-butylÜ-spiroÄisobenzufuran-1(3h),4'-pipéridineÜ.

Country Status (39)

Country Link
US (2) US6844352B2 (no)
EP (1) EP1044202B1 (no)
JP (1) JP3605358B2 (no)
KR (1) KR100399274B1 (no)
CN (1) CN1105115C (no)
AR (1) AR023010A1 (no)
AT (1) ATE288918T1 (no)
AU (1) AU749094B2 (no)
BG (1) BG64906B1 (no)
BR (1) BR9813949A (no)
CA (1) CA2308745C (no)
CZ (1) CZ288666B6 (no)
DE (1) DE69828999T2 (no)
DZ (1) DZ2642A1 (no)
EA (1) EA002092B1 (no)
EG (1) EG23791A (no)
ES (1) ES2234162T3 (no)
HK (1) HK1034075A1 (no)
HR (1) HRP20000261B1 (no)
HU (1) HUP0100991A3 (no)
ID (1) ID25776A (no)
IL (1) IL135723A (no)
IS (1) IS2342B (no)
JO (1) JO2052B1 (no)
MA (1) MA25585A1 (no)
NO (1) NO325920B1 (no)
NZ (1) NZ504065A (no)
PE (1) PE130299A1 (no)
PL (1) PL190538B1 (no)
PT (1) PT1044202E (no)
RS (1) RS49777B (no)
SK (1) SK285245B6 (no)
TN (1) TNSN98201A1 (no)
TR (1) TR200001267T2 (no)
TW (1) TW483894B (no)
UA (1) UA64769C2 (no)
UY (1) UY25236A1 (no)
WO (1) WO1999024436A1 (no)
ZA (1) ZA9810116B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030453A1 (es) * 2000-08-15 2003-08-20 Lundbeck & Co As H Composicion farmaceutica con contenido de 1' [4-[1-(4-fluorofenil)-1h-indol-3-il]-1-butil] espiro [isobenzofuran-1 (3h), 4'-piperidina]
AU2003263155A1 (en) * 2002-09-20 2004-04-08 H. Lundbeck A/S Method for manufacture of dihydroisobenzofuran derivatives
US20050032827A1 (en) 2003-06-12 2005-02-10 Donna Oksenberg Sigma ligands for neuronal regeneration and functional recovery
WO2007012319A1 (de) * 2005-07-29 2007-02-01 Sigma-Aldrich Production Gmbh Ionisierungsadditive enthaltende lc/ms-blends
EP2377530A3 (en) 2005-10-21 2012-06-20 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20070244143A1 (en) * 2006-03-08 2007-10-18 Braincells, Inc Modulation of neurogenesis by nootropic agents
EP2377531A2 (en) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
MX2009002496A (es) * 2006-09-08 2009-07-10 Braincells Inc Combinaciones que contienen un derivado de 4-acilaminopiridina.
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
EP2066355A2 (en) * 2006-09-19 2009-06-10 Braincells, Inc. Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109002A (en) * 1989-09-08 1992-04-28 Du Pont Merck Pharmaceutical Company Antipsychotic 1-cycloalkylpiperidines
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
HUP0100991A3 (en) 2003-03-28
WO1999024436A1 (en) 1999-05-20
SK285245B6 (sk) 2006-09-07
ES2234162T3 (es) 2005-06-16
EG23791A (en) 2007-08-13
AU749094B2 (en) 2002-06-20
PL340220A1 (en) 2001-01-15
DE69828999T2 (de) 2005-07-21
TW483894B (en) 2002-04-21
PL190538B1 (pl) 2005-12-30
TNSN98201A1 (fr) 2005-03-15
MA25585A1 (fr) 2002-12-31
IS5460A (is) 2000-04-18
CA2308745C (en) 2004-01-20
HRP20000261A2 (en) 2001-04-30
EP1044202B1 (en) 2005-02-09
CN1105115C (zh) 2003-04-09
HRP20000261B1 (en) 2009-04-30
EP1044202A1 (en) 2000-10-18
NO20002188L (no) 2000-06-14
KR100399274B1 (ko) 2003-09-26
US20030055074A1 (en) 2003-03-20
ID25776A (id) 2000-11-02
UY25236A1 (es) 2000-12-29
CZ288666B6 (cs) 2001-08-15
UA64769C2 (uk) 2004-03-15
US6844352B2 (en) 2005-01-18
YU23500A (sh) 2003-12-31
HUP0100991A2 (hu) 2001-09-28
CN1278823A (zh) 2001-01-03
AU1022699A (en) 1999-05-31
ZA9810116B (en) 1999-05-07
TR200001267T2 (tr) 2000-09-21
DE69828999D1 (de) 2005-03-17
EA200000502A1 (ru) 2000-10-30
CZ20001663A3 (cs) 2000-10-11
BG104485A (en) 2001-01-31
IL135723A0 (en) 2001-05-20
HK1034075A1 (en) 2001-10-12
SK6462000A3 (en) 2000-10-09
IS2342B (is) 2008-02-15
US20050171135A1 (en) 2005-08-04
NO325920B1 (no) 2008-08-18
JP3605358B2 (ja) 2004-12-22
PE130299A1 (es) 1999-12-16
RS49777B (sr) 2008-06-05
KR20010031791A (ko) 2001-04-16
IL135723A (en) 2005-11-20
CA2308745A1 (en) 1999-05-20
ATE288918T1 (de) 2005-02-15
JP2001522852A (ja) 2001-11-20
BG64906B1 (bg) 2006-08-31
JO2052B1 (en) 1999-05-15
NO20002188D0 (no) 2000-04-27
BR9813949A (pt) 2000-09-26
AR023010A1 (es) 2002-09-04
NZ504065A (en) 2002-05-31
EA002092B1 (ru) 2001-12-24
PT1044202E (pt) 2005-04-29

Similar Documents

Publication Publication Date Title
SV1996000005A (es) Quinazolinonas bisustituidas en 2,8
IS4963A (is) Setnar 6,5-heteró-bísýklískar afleiður
TR199800444A3 (tr) Hipolipidemik 1,4-benzotiazepin-1,1-diyoksitler.
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
NL300150I1 (nl) 4"-Gesubstitueerde 9-deoxo-9A-AZA-9A-homoërythromycine-A-derivaten.
PT901487E (pt) 4(3h)-quinazolinonas 2,3,6-trissubstituidas
TR28098A (tr) 1,2,4-okzadiazol türevleri.
TR27961A (tr) Sübstitüe edilmis 1,2,3,4 -tetrahidro-5-nitro-pirimidinler.
DK1015467T3 (da) 6,9-brobundne erythromycinderivater
DZ2642A1 (fr) Hydrohalogénures 1'-Ä4-Ä1-(fluorphényl)-1h-indole-3ylÜ-1-butylÜ-spiroÄisobenzufuran-1(3h),4'-pipéridineÜ.
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
DE69814441D1 (de) 6,11-verbrückte erythromycinderivate
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
ZA973984B (en) 2,4-diaminopyrimidine derivatives.
ZA982327B (en) Substituted 2-benz(O)ylpyridines.
ID26909A (id) Turunan-turunan 1,3,4-oksadiazolon
DE69906149D1 (de) 4,5-azolo-oxindole
TR199501562A2 (tr) Tiyenopiridon'lar.
ZA986160B (en) 2,4,4-trisubstituted-1,3-dioxolone antifungals.
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
ID26368A (id) Turunan-turunan 2 deoksi higromisin
TR199700219A3 (tr) 1,25-Dihidroksi-16, 22, 23-Trisdihidro-kolkalsiferol türevleri.
ZA984592B (en) Herbicidal 3,5-difluoropyridines.
TR199600579A2 (tr) N-N-Dietil-8,8-Dipropil-2-Azaspiro (4.5) Dekan-2-propanamid dimaleat.